Ticagrelor in clopidogrel-resistant patients undergoing maintenance hemodialysis

American Journal of Kidney Diseases

Volumn 60, Issue 2, 2012, Pages 332-333

  Alexopoulos, Dimitrios ^a   Xanthopoulou, Ioanna ^a   Plakomyti, Theodora Eleni ^a   Goudas, Pavlos ^b   Koutroulia, Eleni ^b   Goumenos, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b 'Ag Andreas' Patras Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR; TICAGRELOR;

AGED; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DRUG INDICATION; FEMALE; HEMODIALYSIS; HUMAN; LETTER; MALE; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBOSIS; TREATMENT RESPONSE; VASCULAR ACCESS;

ADENOSINE; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; DRUG RESISTANCE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RENAL DIALYSIS; TICLOPIDINE;

EID: 84863989810     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.05.001     Document Type: Letter

References (10)

1. S.H. Park, W. Kim, C.S. Park, W.Y. Kang, S.H. Hwang, W. Kim A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure Am J Cardiol 104 9 2009 1292 1295
2. J.S. Woo, W. Kim, S.R. Lee Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized study Am Heart J 162 6 2011 1018 1025
3. D. Alexopoulos, I. Xanthopoulou, A. Panagiotou Prevalence of inadequate platelet inhibition by clopidogrel in patients receiving hemodialysis Am J Kidney Dis 59 3 2012 469 471
4. S. James, A. Budaj, P. Aylward Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial Circulation 122 11 2010 1056 1067
5. L. Bonello, U.S. Tantry, R. Marcucci Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 12 2010 919 933
6. D. Sibbing, S. Braun, S. Jawansky Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment Thromb Haemost 99 1 2008 121 126
7. D. Alexopoulos, A. Panagiotou, I. Xanthopoulou Antiplatelet effects of pasugrel vs double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity J Thromb Haemost 9 12 2011 2379 2385
8. L. Wallentin, R.C. Becker, A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 11 2009 1045 1057
9. Butler K, Teng R. Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairment [published online ahead of print September 29, 2011]. J Clin Pharmacol. doi:10.1177/0091270011415526.
10. P.A. Gurbel, K.P. Bliden, K. Butler Randomized double-blind assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease: the ONSET/OFFSET Study Circulation 120 25 2009 2577 2585